<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-10-10" modified="2017-12-20" version="128">
<accession>Q8IXQ6</accession>
<accession>A8KA94</accession>
<accession>B2R8S9</accession>
<accession>E9PFM7</accession>
<accession>Q8TCP3</accession>
<accession>Q9BZL8</accession>
<accession>Q9BZL9</accession>
<name>PARP9_HUMAN</name>
<protein>
<recommendedName>
<fullName>Poly [ADP-ribose] polymerase 9</fullName>
<shortName>PARP-9</shortName>
<ecNumber evidence="3 13">2.4.2.30</ecNumber>
</recommendedName>
<alternativeName>
<fullName>ADP-ribosyltransferase diphtheria toxin-like 9</fullName>
<shortName>ARTD9</shortName>
</alternativeName>
<alternativeName>
<fullName>B aggressive lymphoma protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PARP9</name>
<name type="synonym">BAL</name>
<name type="synonym">BAL1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Blood" volume="96" first="4328" last="4334">
<title>BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration.</title>
<authorList>
<person name="Aguiar R.C.T."/>
<person name="Yakushijin Y."/>
<person name="Kharbanda S."/>
<person name="Salgia R."/>
<person name="Fletcher J.A."/>
<person name="Shipp M.A."/>
</authorList>
<dbReference type="PubMed" id="11110709"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT CYS-528</scope>
<scope>INVOLVEMENT IN B-CELL LYMPHOMAS</scope>
<source>
<tissue>B-cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>VARIANT CYS-528</scope>
<source>
<tissue>Trachea</tissue>
<tissue>Umbilical cord blood</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1194" last="1198">
<title>The DNA sequence, annotation and analysis of human chromosome 3.</title>
<authorList>
<person name="Muzny D.M."/>
<person name="Scherer S.E."/>
<person name="Kaul R."/>
<person name="Wang J."/>
<person name="Yu J."/>
<person name="Sudbrak R."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Wei S."/>
<person name="Wheeler D.A."/>
<person name="Wright M.W."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clendenning J."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Chen R."/>
<person name="Chen Z."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Dong W."/>
<person name="Draper H."/>
<person name="Ernst S."/>
<person name="Fu G."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Garcia D.K."/>
<person name="Gillett W."/>
<person name="Gu J."/>
<person name="Hao B."/>
<person name="Haugen E."/>
<person name="Havlak P."/>
<person name="He X."/>
<person name="Hennig S."/>
<person name="Hu S."/>
<person name="Huang W."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Kube M."/>
<person name="Levy R."/>
<person name="Li Z."/>
<person name="Liu B."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Palmeiri A."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Phelps K.A."/>
<person name="Plopper F.J."/>
<person name="Qiang B."/>
<person name="Raymond C."/>
<person name="Rodriguez R."/>
<person name="Saenphimmachak C."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Shen Y."/>
<person name="Subramanian S."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang J."/>
<person name="Wang J."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Wong G.K.-S."/>
<person name="Yao Z."/>
<person name="Zhang J."/>
<person name="Zhang X."/>
<person name="Zhao G."/>
<person name="Zhou J."/>
<person name="Zhou Y."/>
<person name="Nelson D."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Naylor S.L."/>
<person name="Yang H."/>
<person name="Olson M."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16641997"/>
<dbReference type="DOI" id="10.1038/nature04728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3)</scope>
<scope>VARIANTS VAL-517 AND CYS-528</scope>
<source>
<tissue>Mammary gland</tissue>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 525-854</scope>
<source>
<tissue>Amygdala</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="21930" last="21937">
<title>The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity.</title>
<authorList>
<person name="Takeyama K."/>
<person name="Aguiar R.C.T."/>
<person name="Gu L."/>
<person name="He C."/>
<person name="Freeman G.J."/>
<person name="Kutok J.L."/>
<person name="Aster J.C."/>
<person name="Shipp M.A."/>
</authorList>
<dbReference type="PubMed" id="12670957"/>
<dbReference type="DOI" id="10.1074/jbc.M301157200"/>
</citation>
<scope>INTERACTION WITH DTX3L</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="5348" last="5359">
<title>BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate.</title>
<authorList>
<person name="Juszczynski P."/>
<person name="Kutok J.L."/>
<person name="Li C."/>
<person name="Mitra J."/>
<person name="Aguiar R.C.T."/>
<person name="Shipp M.A."/>
</authorList>
<dbReference type="PubMed" id="16809771"/>
<dbReference type="DOI" id="10.1128/MCB.02351-05"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2010" name="Trends Biochem. Sci." volume="35" first="208" last="219">
<title>Toward a unified nomenclature for mammalian ADP-ribosyltransferases.</title>
<authorList>
<person name="Hottiger M.O."/>
<person name="Hassa P.O."/>
<person name="Luscher B."/>
<person name="Schuler H."/>
<person name="Koch-Nolte F."/>
</authorList>
<dbReference type="PubMed" id="20106667"/>
<dbReference type="DOI" id="10.1016/j.tibs.2009.12.003"/>
</citation>
<scope>NOMENCLATURE</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="845" last="857">
<title>BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8.</title>
<authorList>
<person name="Yan Q."/>
<person name="Xu R."/>
<person name="Zhu L."/>
<person name="Cheng X."/>
<person name="Wang Z."/>
<person name="Manis J."/>
<person name="Shipp M.A."/>
</authorList>
<dbReference type="PubMed" id="23230272"/>
<dbReference type="DOI" id="10.1128/MCB.00990-12"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PARP1</scope>
<scope>DOMAIN MACRO 2</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2015" name="Nat. Immunol." volume="16" first="1215" last="1227">
<title>PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Mao D."/>
<person name="Roswit W.T."/>
<person name="Jin X."/>
<person name="Patel A.C."/>
<person name="Patel D.A."/>
<person name="Agapov E."/>
<person name="Wang Z."/>
<person name="Tidwell R.M."/>
<person name="Atkinson J.J."/>
<person name="Huang G."/>
<person name="McCarthy R."/>
<person name="Yu J."/>
<person name="Yun N.E."/>
<person name="Paessler S."/>
<person name="Lawson T.G."/>
<person name="Omattage N.S."/>
<person name="Brett T.J."/>
<person name="Holtzman M.J."/>
</authorList>
<dbReference type="PubMed" id="26479788"/>
<dbReference type="DOI" id="10.1038/ni.3279"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DTX3L AND STAT1</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH DTX3L; STAT1 AND HIST1H2BH</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF GLY-147 AND GLY-346</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2016" name="Nat. Commun." volume="7" first="12849" last="12849">
<title>PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation.</title>
<authorList>
<person name="Iwata H."/>
<person name="Goettsch C."/>
<person name="Sharma A."/>
<person name="Ricchiuto P."/>
<person name="Goh W.W."/>
<person name="Halu A."/>
<person name="Yamada I."/>
<person name="Yoshida H."/>
<person name="Hara T."/>
<person name="Wei M."/>
<person name="Inoue N."/>
<person name="Fukuda D."/>
<person name="Mojcher A."/>
<person name="Mattson P.C."/>
<person name="Barabasi A.L."/>
<person name="Boothby M."/>
<person name="Aikawa E."/>
<person name="Singh S.A."/>
<person name="Aikawa M."/>
</authorList>
<dbReference type="PubMed" id="27796300"/>
<dbReference type="DOI" id="10.1038/ncomms12849"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PARP14</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
<scope>ADP-RIBOSYLATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2017" name="Mol. Cell" volume="66" first="503" last="516">
<title>Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.</title>
<authorList>
<person name="Yang C.S."/>
<person name="Jividen K."/>
<person name="Spencer A."/>
<person name="Dworak N."/>
<person name="Ni L."/>
<person name="Oostdyk L.T."/>
<person name="Chatterjee M."/>
<person name="Kusmider B."/>
<person name="Reon B."/>
<person name="Parlak M."/>
<person name="Gorbunova V."/>
<person name="Abbas T."/>
<person name="Jeffery E."/>
<person name="Sherman N.E."/>
<person name="Paschal B.M."/>
</authorList>
<dbReference type="PubMed" id="28525742"/>
<dbReference type="DOI" id="10.1016/j.molcel.2017.04.028"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH WITH DTX3L</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF GLY-147; GLY-346; 719-GLY--ARG-722; TYR-737; PHE-738; 766-VAL--GLY-769; 780-VAL--LEU-784; 802-PRO--GLU-803 AND 831-TYR--ASP-854</scope>
</reference>
<reference key="13">
<citation type="submission" date="2015-02" db="PDB data bank">
<title>Structure of Parp9 2Nd Macrodomain.</title>
<authorList>
<person name="Elkins J.M."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 310-493</scope>
</reference>
<comment type="function">
<text evidence="2 9 10 11 12 13">ADP-ribosyltransferase which, in association with E3 ligase DTX3L, plays a role in DNA damage repair and in immune responses including interferon-mediated antiviral defenses (PubMed:16809771, PubMed:23230272, PubMed:26479788, PubMed:27796300). Within the complex, enhances DTX3L E3 ligase activity which is further enhanced by PARP9 binding to poly(ADP-ribose) (PubMed:28525742). In association with DTX3L and in presence of E1 and E2 enzymes, mediates NAD(+)-dependent mono-ADP-ribosylation of ubiquitin which prevents ubiquitin conjugation to substrates such as histones (PubMed:28525742). During DNA repair, PARP1 recruits PARP9/BAL1-DTX3L complex to DNA damage sites via PARP9 binding to ribosylated PARP1 (PubMed:23230272). Subsequent PARP1-dependent PARP9/BAL1-DTX3L-mediated ubiquitination promotes the rapid and specific recruitment of 53BP1/TP53BP1, UIMC1/RAP80, and BRCA1 to DNA damage sites (PubMed:23230272, PubMed:28525742). In response to DNA damage, PARP9-DTX3L complex is required for efficient non-homologous end joining (NHEJ); the complex function is negatively modulated by PARP9 activity (PubMed:28525742). Dispensable for B-cell receptor (BCR) assembly through V(D)J recombination and class switch recombination (CSR) (By similarity). In macrophages, positively regulates pro-inflammatory cytokines production in response to IFNG stimulation by suppressing PARP14-mediated STAT1 ADP-ribosylation and thus promoting STAT1 phosphorylation (PubMed:27796300). Also suppresses PARP14-mediated STAT6 ADP-ribosylation (PubMed:27796300).</text>
</comment>
<comment type="catalytic activity">
<text evidence="3 13">NAD(+) + (ADP-D-ribosyl)(n)-acceptor = nicotinamide + (ADP-D-ribosyl)(n+1)-acceptor.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="13">Binding to poly(ADP-ribose) does not affect its activity.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="13">196 uM for NAD(+)</KM>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="6 10 11 12 13">Forms a stable complex with E3 ligase DTX3L; the interaction is required for PARP9 mediated ADP-ribosylation of ubiquitin (PubMed:12670957, PubMed:28525742). Interacts (via PARP catalytic domain) with DTX3L (via N-terminus) (PubMed:26479788). Forms a complex with STAT1 and DTX3L independently of IFNB1 or IFNG-mediated STAT1 'Tyr-701' phosphorylation (PubMed:26479788). Forms a complex with STAT1, DTX3L and histone H2B HIST1H2BH/H2BJ; the interaction is likely to induce HIST1H2BH/H2BJ ubiquitination (PubMed:26479788). Interacts (via N-terminus) with STAT1 (PubMed:26479788). Interacts with PARP14 in IFNG-stimulated macrophages; the interaction prevents PARP14-mediated STAT1 and STAT6 ADP-riboslylation (PubMed:27796300). Interacts with PARP1 (when poly-ADP-ribosylated) (PubMed:23230272).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="9 11 12">Cytoplasm</location>
<location evidence="9 11 12">cytosol</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="5 9 10 11 13">Nucleus</location>
</subcellularLocation>
<text evidence="9 10 11 13">Shuttles between the nucleus and the cytosol (PubMed:16809771). Translocates to the nucleus in response to IFNG or IFNB1 stimulation (PubMed:26479788). Export to the cytosol depends on the interaction with DTX3L (PubMed:16809771). Localizes at sites of DNA damage in a PARP1-dependent manner (PubMed:23230272, PubMed:28525742).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q8IXQ6-1</id>
<name>1</name>
<name>Long</name>
<name>L</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q8IXQ6-2</id>
<name>2</name>
<name>Short</name>
<name>S</name>
<sequence type="described" ref="VSP_008505"/>
</isoform>
<isoform>
<id>Q8IXQ6-3</id>
<name>3</name>
<sequence type="described" ref="VSP_008505 VSP_046086 VSP_046087"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="5 9 12">Expressed in lymphocyte-rich tissues, spleen, lymph nodes, peripheral blood lymphocytes and colonic mucosa (PubMed:11110709, PubMed:16809771). Expressed in macrophages (PubMed:27796300). Also expressed in nonhematopoietic tissues such as heart and skeletal muscle (PubMed:11110709, PubMed:16809771). Isoform 2 is the predominant form (PubMed:11110709). Most abundantly expressed in lymphomas with a brisk host inflammatory response (PubMed:11110709, PubMed:16809771). In diffuse large B-cell lymphomas tumors, expressed specifically by malignant B-cells (PubMed:11110709, PubMed:16809771).</text>
</comment>
<comment type="induction">
<text evidence="9 11 12">Up-regulated by IFNG in macrophages and in B-cell lymphoma cell lines (PubMed:16809771, PubMed:27796300, PubMed:26479788). Up-regulated by IFNB1 or viral infection (PubMed:26479788). Down-regulated by IL4 in macrophages (PubMed:27796300).</text>
</comment>
<comment type="domain">
<text evidence="10 11 13">Macro domains 1 and 2 may be involved in the binding to poly(ADP-ribose) (PubMed:28525742, PubMed:26479788). Macro domain 2 is required for recruitment to DNA damage sites (PubMed:23230272). Macro domains 1 and 2 are probably dispensable for the interaction with STAT1 and DTX3L and for STAT1 phosphorylation (PubMed:26479788).</text>
</comment>
<comment type="PTM">
<text evidence="12">ADP-ribosylated by PARP14.</text>
</comment>
<comment type="disease">
<text evidence="5">Overexpressed at significantly higher levels in fatal high-risk diffuse large B-cell lymphomas (DLB-CL) compared to cured low-risk tumors. Overexpression in B-cell lymphoma transfectants may promote malignant B-cell migration. May therefore be involved in promoting B-cell migration and dissemination of high-risk DLB-CL tumors (PubMed:11110709).</text>
</comment>
<dbReference type="EC" id="2.4.2.30" evidence="3 13"/>
<dbReference type="EMBL" id="AF307338">
<property type="protein sequence ID" value="AAK07558.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF307339">
<property type="protein sequence ID" value="AAK07559.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292959">
<property type="protein sequence ID" value="BAF85648.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313494">
<property type="protein sequence ID" value="BAG36276.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC092908">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC096861">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC017463">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC039580">
<property type="protein sequence ID" value="AAH39580.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL713679">
<property type="protein sequence ID" value="CAD28483.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3014.1">
<molecule id="Q8IXQ6-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54633.1">
<molecule id="Q8IXQ6-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54634.1">
<molecule id="Q8IXQ6-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001139574.1">
<molecule id="Q8IXQ6-1"/>
<property type="nucleotide sequence ID" value="NM_001146102.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001139575.1">
<molecule id="Q8IXQ6-2"/>
<property type="nucleotide sequence ID" value="NM_001146103.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001139576.1">
<molecule id="Q8IXQ6-2"/>
<property type="nucleotide sequence ID" value="NM_001146104.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001139577.1">
<molecule id="Q8IXQ6-2"/>
<property type="nucleotide sequence ID" value="NM_001146105.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_113646.2">
<molecule id="Q8IXQ6-1"/>
<property type="nucleotide sequence ID" value="NM_031458.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005247877.1">
<molecule id="Q8IXQ6-1"/>
<property type="nucleotide sequence ID" value="XM_005247820.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016862793.1">
<molecule id="Q8IXQ6-1"/>
<property type="nucleotide sequence ID" value="XM_017007304.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016862794.1">
<molecule id="Q8IXQ6-2"/>
<property type="nucleotide sequence ID" value="XM_017007305.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016862795.1">
<molecule id="Q8IXQ6-2"/>
<property type="nucleotide sequence ID" value="XM_017007306.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.518200"/>
<dbReference type="PDB" id="5AIL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A/B=310-493"/>
</dbReference>
<dbReference type="PDBsum" id="5AIL"/>
<dbReference type="ProteinModelPortal" id="Q8IXQ6"/>
<dbReference type="SMR" id="Q8IXQ6"/>
<dbReference type="BioGrid" id="123723">
<property type="interactions" value="11"/>
</dbReference>
<dbReference type="IntAct" id="Q8IXQ6">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000353512"/>
<dbReference type="iPTMnet" id="Q8IXQ6"/>
<dbReference type="PhosphoSitePlus" id="Q8IXQ6"/>
<dbReference type="BioMuta" id="PARP9"/>
<dbReference type="DMDM" id="48474734"/>
<dbReference type="EPD" id="Q8IXQ6"/>
<dbReference type="MaxQB" id="Q8IXQ6"/>
<dbReference type="PaxDb" id="Q8IXQ6"/>
<dbReference type="PeptideAtlas" id="Q8IXQ6"/>
<dbReference type="PRIDE" id="Q8IXQ6"/>
<dbReference type="Ensembl" id="ENST00000360356">
<molecule id="Q8IXQ6-1"/>
<property type="protein sequence ID" value="ENSP00000353512"/>
<property type="gene ID" value="ENSG00000138496"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000462315">
<molecule id="Q8IXQ6-3"/>
<property type="protein sequence ID" value="ENSP00000418894"/>
<property type="gene ID" value="ENSG00000138496"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000471785">
<molecule id="Q8IXQ6-2"/>
<property type="protein sequence ID" value="ENSP00000419001"/>
<property type="gene ID" value="ENSG00000138496"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000477522">
<molecule id="Q8IXQ6-2"/>
<property type="protein sequence ID" value="ENSP00000419506"/>
<property type="gene ID" value="ENSG00000138496"/>
</dbReference>
<dbReference type="GeneID" id="83666"/>
<dbReference type="KEGG" id="hsa:83666"/>
<dbReference type="UCSC" id="uc003efh.5">
<molecule id="Q8IXQ6-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="83666"/>
<dbReference type="DisGeNET" id="83666"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000138496.16"/>
<dbReference type="GeneCards" id="PARP9"/>
<dbReference type="HGNC" id="HGNC:24118">
<property type="gene designation" value="PARP9"/>
</dbReference>
<dbReference type="HPA" id="HPA066708"/>
<dbReference type="MIM" id="612065">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8IXQ6"/>
<dbReference type="OpenTargets" id="ENSG00000138496"/>
<dbReference type="PharmGKB" id="PA134870403"/>
<dbReference type="eggNOG" id="KOG2633">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG2110">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119084"/>
<dbReference type="HOGENOM" id="HOG000115452"/>
<dbReference type="HOVERGEN" id="HBG045406"/>
<dbReference type="InParanoid" id="Q8IXQ6"/>
<dbReference type="KO" id="K15260"/>
<dbReference type="OMA" id="SGIFQFP"/>
<dbReference type="OrthoDB" id="EOG091G02AK"/>
<dbReference type="PhylomeDB" id="Q8IXQ6"/>
<dbReference type="TreeFam" id="TF328965"/>
<dbReference type="Reactome" id="R-HSA-197264">
<property type="pathway name" value="Nicotinamide salvaging"/>
</dbReference>
<dbReference type="GenomeRNAi" id="83666"/>
<dbReference type="PRO" id="PR:Q8IXQ6"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000138496"/>
<dbReference type="CleanEx" id="HS_PARP9"/>
<dbReference type="ExpressionAtlas" id="Q8IXQ6">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q8IXQ6">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090734">
<property type="term" value="C:site of DNA damage"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072570">
<property type="term" value="F:ADP-D-ribose binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004857">
<property type="term" value="F:enzyme inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042393">
<property type="term" value="F:histone binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003950">
<property type="term" value="F:NAD+ ADP-ribosyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097677">
<property type="term" value="F:STAT family protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001191">
<property type="term" value="F:transcriptional repressor activity, RNA polymerase II transcription factor binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044389">
<property type="term" value="F:ubiquitin-like protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006302">
<property type="term" value="P:double-strand break repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0034356">
<property type="term" value="P:NAD biosynthesis via nicotinamide riboside salvage pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043086">
<property type="term" value="P:negative regulation of catalytic activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035563">
<property type="term" value="P:positive regulation of chromatin binding"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002230">
<property type="term" value="P:positive regulation of defense response to virus by host"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001034">
<property type="term" value="P:positive regulation of double-strand break repair via nonhomologous end joining"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060335">
<property type="term" value="P:positive regulation of interferon-gamma-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900182">
<property type="term" value="P:positive regulation of protein localization to nucleus"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042531">
<property type="term" value="P:positive regulation of tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010608">
<property type="term" value="P:posttranscriptional regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006471">
<property type="term" value="P:protein ADP-ribosylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060330">
<property type="term" value="P:regulation of response to interferon-gamma"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR002589">
<property type="entry name" value="Macro_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR012317">
<property type="entry name" value="Poly(ADP-ribose)pol_cat_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF01661">
<property type="entry name" value="Macro"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00506">
<property type="entry name" value="A1pp"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS51154">
<property type="entry name" value="MACRO"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS51059">
<property type="entry name" value="PARP_CATALYTIC"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0013">ADP-ribosylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Poly [ADP-ribose] polymerase 9" id="PRO_0000211339">
<location>
<begin position="1"/>
<end position="854"/>
</location>
</feature>
<feature type="domain" description="Macro 1" evidence="4">
<location>
<begin position="107"/>
<end position="296"/>
</location>
</feature>
<feature type="domain" description="Macro 2" evidence="4">
<location>
<begin position="306"/>
<end position="487"/>
</location>
</feature>
<feature type="domain" description="PARP catalytic" evidence="3">
<location>
<begin position="628"/>
<end position="850"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_008505" evidence="14 15 16">
<location>
<begin position="17"/>
<end position="51"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_046086" evidence="16">
<original>DPKYGAGIYFTKNLKNL</original>
<variation>GRCQCLIIGATLWNLVS</variation>
<location>
<begin position="729"/>
<end position="745"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_046087" evidence="16">
<location>
<begin position="746"/>
<end position="854"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34006803." id="VAR_056654">
<original>S</original>
<variation>L</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28365795." id="VAR_056655" evidence="8">
<original>I</original>
<variation>V</variation>
<location>
<position position="517"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9851180." id="VAR_056656" evidence="5 7 8">
<original>Y</original>
<variation>C</variation>
<location>
<position position="528"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6780543." id="VAR_056657">
<original>T</original>
<variation>A</variation>
<location>
<position position="651"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces the binding to poly(ADP-ribose) by 50 percent and prevents increase in DTX3L-mediated histone ubiquitination without affecting ubiquitin ADP ribosylation, interaction with DTX3L and STAT1 and DTX3L catalytic activity; when associated with E-346." evidence="11 13">
<original>G</original>
<variation>E</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces the binding to poly(ADP-ribose) by 50 percent and prevents increase in DTX3L-mediated histone ubiquitination without affecting ubiquitin ADP ribosylation, interaction with DTX3L and STAT1 and DTX3L catalytic activity; when associated with E-147." evidence="11 13">
<original>G</original>
<variation>E</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ADP ribosylation activity and interaction with DTX3L." evidence="13">
<location>
<begin position="719"/>
<end position="722"/>
</location>
</feature>
<feature type="mutagenesis site" description="No defect in ubiquitin ADP ribosylation and the interaction with DTX3L." evidence="13">
<original>Y</original>
<variation>A</variation>
<location>
<position position="737"/>
</location>
</feature>
<feature type="mutagenesis site" description="Severe reduction in ubiquitin ADP ribosylation. No effect on the interaction with DTX3L and on DTX3L E3 ligase activity. Increases DNA repair." evidence="13">
<original>F</original>
<variation>K</variation>
<location>
<position position="738"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ADP ribosylation activity and interaction with DTX3L." evidence="13">
<location>
<begin position="766"/>
<end position="769"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces ADP ribosylation activity and interaction with DTX3L." evidence="13">
<location>
<begin position="780"/>
<end position="784"/>
</location>
</feature>
<feature type="mutagenesis site" description="No defect in ADP ribosylation and interaction with DTX3L." evidence="13">
<original>PE</original>
<variation>AA</variation>
<location>
<begin position="802"/>
<end position="803"/>
</location>
</feature>
<feature type="mutagenesis site" description="No defect in ADP ribosylation and interaction with DTX3L." evidence="13">
<location>
<begin position="831"/>
<end position="854"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAF85648." ref="2" evidence="17">
<original>S</original>
<variation>P</variation>
<location>
<position position="487"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG36276." ref="2" evidence="17">
<original>F</original>
<variation>S</variation>
<location>
<position position="839"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="311"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="317"/>
<end position="324"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="326"/>
<end position="328"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="330"/>
<end position="339"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="347"/>
<end position="356"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="358"/>
<end position="370"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="378"/>
<end position="382"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="386"/>
<end position="395"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="402"/>
<end position="419"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="423"/>
<end position="427"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="433"/>
<end position="437"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="439"/>
<end position="456"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="462"/>
<end position="468"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="473"/>
<end position="490"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5AIL"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8CAS9"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00397"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00490"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11110709"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12670957"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16809771"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23230272"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26479788"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27796300"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28525742"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11110709"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000305"/>
<sequence length="854" mass="96343" checksum="CBBB3B4B7CA1CDA4" modified="2003-10-10" version="2">
MDFSMVAGAAAYNEKSGRITSLSLLFQKVFAQIFPQWRKGNTEECLPYKCSETGALGENY
SWQIPINHNDFKILKNNERQLCEVLQNKFGCISTLVSPVQEGNSKSLQVFRKMLTPRIEL
SVWKDDLTTHAVDAVVNAANEDLLHGGGLALALVKAGGFEIQEESKQFVARYGKVSAGEI
AVTGAGRLPCKQIIHAVGPRWMEWDKQGCTGKLQRAIVSILNYVIYKNTHIKTVAIPALS
SGIFQFPLNLCTKTIVETIRVSLQGKPMMSNLKEIHLVSNEDPTVAAFKAASEFILGKSE
LGQETTPSFNAMVVNNLTLQIVQGHIEWQTADVIVNSVNPHDITVGPVAKSILQQAGVEM
KSEFLATKAKQFQRSQLVLVTKGFNLFCKYIYHVLWHSEFPKPQILKHAMKECLEKCIEQ
NITSISFPALGTGNMEIKKETAAEILFDEVLTFAKDHVKHQLTVKFVIFPTDLEIYKAFS
SEMAKRSKMLSLNNYSVPQSTREEKRENGLEARSPAINLMGFNVEEMYEAHAWIQRILSL
QNHHIIENNHILYLGRKEHDILSQLQKTSSVSITEIISPGRTELEIEGARADLIEVVMNI
EDMLCKVQEEMARKKERGLWRSLGQWTIQQQKTQDEMKENIIFLKCPVPPTQELLDQKKQ
FEKCGLQVLKVEKIDNEVLMAAFQRKKKMMEEKLHRQPVSHRLFQQVPYQFCNVVCRVGF
QRMYSTPCDPKYGAGIYFTKNLKNLAEKAKKISAADKLIYVFEAEVLTGFFCQGHPLNIV
PPPLSPGAIDGHDSVVDNVSSPETFVIFSGMQAIPQYLWTCTQEYVQSQDYSSGPMRPFA
QHPWRGFASGSPVD
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>